Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of PF-06252616 in male participants (Japan)
jRCT2080222786Phase 2Terminated
- Start
- Mar 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of domagrozumab. Started Mar 2015; status: terminated.
02
Drugs
domagrozumab
Beyond the preview
Go deeper on jRCT2080222786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222786.